Latest filing published 22 Mar 2017 for Aurinia Pharmaceuticals Inc..
Insider track record
No signal scores available.
ILJIN Lifescience Co., Ltd.: trading record in brief
ILJIN Lifescience Co., Ltd. discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 20 September 2016 to 20 March 2017.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 22 March 2017, reports a transaction in Aurinia Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to ILJIN Lifescience Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,586,606 sharesCommon SharesTSXSEDI:2982221
- 333,333 shares@ CA$2.50100.0% of flowCommon SharesTSXSEDI:2900488
2 of 2 declarations
